Intranasal versus intravenous AAV delivery: A comparative analysis of brain-targeting efficiency and peripheral exposure in mice

by Biotech Newsroom


  • Fiandaca MS, Lonser RR, Elder JB, Ząbek M, Bankiewicz KS. Advancing gene therapies, methods, and technologies for Parkinson’s Disease and other neurological disorders. Neurol Neurochir Pol. 2020;54:220–31.

    Article 
    PubMed 

    Google Scholar
     

  • Pena SA, Iyengar R, Eshraghi RS, Bencie N, Mittal J, Aljohani A, et al. Gene therapy for neurological disorders: challenges and recent advancements. J Drug Target. 2020;28:111–28.

    Article 
    CAS 
    PubMed 

    Google Scholar
     



  • Source link

    You may also like

    Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

    Free Magazines

    Recent Articles

    BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC